Bezos, Elon Musk and Zuckerberg Betting Big on S.C.G.
The "Black Box" Device Bringing the Age of the Smartphone to an End.
Learn More
William Ho, insider at RAPT Therapeutics
William Ho Insider Alerts

Get notified the next time William Ho buys or sells RAPT Therapeutics stock. Enter your email address below to get our daily insider buying and selling report.

William Ho Insider Information

Insider of RAPT Therapeutics
Bill joined RAPT Therapeutics as Chief Medical Officer in 2015, bringing with him extensive experience both in clinical immunotherapy and in the translational and clinical development of novel therapeutics to treat cancer. He joined RAPT Therapeutics after serving as the Vice President of Clinical Development at Igenica Biotherapeutics, where he led the clinical development of antibody-based therapeutics. Prior to Igenica, Bill served as a Senior Medical Director in the Exploratory Clinical Development (BioOncology) group at Genentech, where for seven years he led the development of multiple small molecule, antibody, and antibody-drug conjugate programs from IND filing to Phase III, including clinical development of Gazyva® (obinutuzumab), Venclexta™ (venetoclax) and Polivy™ (polatuzumab vedotin-piiq).

Bill received his A.B. in Molecular Biology from Princeton University and both his M.D. and his Ph.D. in Microbiology and Immunology from the Stanford University School of Medicine, where he studied cellular immunology in the laboratory of Mark Davis, Ph.D. Bill completed his internship and residency in Internal Medicine at the University of California, San Francisco, and received his training in Medical Oncology at the University of Washington and Fred Hutchinson Cancer Research Center, where he studied adoptive immunotherapy methods to treat leukemia.

What is William Ho's net worth?

The estimated net worth of William Ho is at least $1.36 million as of July 15th, 2021. Dr. Ho owns 57,529 shares of RAPT Therapeutics stock worth more than $1,358,260 as of January 20th. This net worth estimate does not reflect any other investments that Dr. Ho may own. Learn More.

What is William Ho's salary?

As the Insider of RAPT Therapeutics, Inc., Dr. Ho earned a total compensation package of $1,520,814.00 in 2020. Dr. Ho earned a salary of $400,000.00, options awards of $990,814.00, non-equity compensation of $130,000.00, and no other miscellaneous compensation.

How do I contact William Ho?

The corporate mailing address for Dr. Ho and other RAPT Therapeutics executives is 561 ECCLES AVENUE, SOUTH SAN FRANCISCO CA, 94080. RAPT Therapeutics can also be reached via phone at (650) 489-9000 and via email at [email protected]

Has William Ho been buying or selling shares of RAPT Therapeutics?

During the last ninety days, William Ho has sold $172,010.00 in shares of RAPT Therapeutics stock. Most recently, William Ho sold 3,000 shares of the business's stock in a transaction on Thursday, January 13th. The shares were sold at an average price of $30.67, for a transaction totalling $92,010.00.

Who are RAPT Therapeutics' active insiders?

RAPT Therapeutics' insider roster includes Dirk Brockstedt (Insider), William Ho (Insider), and Wendye Robbins (Director).

Are insiders buying or selling shares of RAPT Therapeutics?

In the last twelve months, RAPT Therapeutics insiders bought shares 8 times. They purchased a total of 5,975 shares worth more than $169,796.25. In the last twelve months, insiders at the sold shares 37 times. They sold a total of 319,636 shares worth more than $8,924,763.25. The most recent insider tranaction occured on January, 13th when insider William Ho sold 3,000 shares worth more than $92,010.00. Insiders at RAPT Therapeutics own 26.3 % of the company.

Information on this page was last updated on 1/13/2022.

William Ho Insider Trading History at RAPT Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/13/2022Sell3,000$30.67$92,010.00View SEC Filing Icon  
1/5/2022Sell2,000$40.00$80,000.00View SEC Filing Icon  
12/3/2021Sell3,000$32.26$96,780.00View SEC Filing Icon  
10/13/2021Sell3,000$29.69$89,070.00View SEC Filing Icon  
9/20/2021Sell2,000$40.00$80,000.00View SEC Filing Icon  
9/17/2021Sell2,000$38.97$77,940.00View SEC Filing Icon  
9/8/2021Sell3,000$36.04$108,120.00View SEC Filing Icon  
8/16/2021Sell1,000$32.07$32,070.00View SEC Filing Icon  
8/2/2021Sell1,000$30.52$30,520.00View SEC Filing Icon  
7/15/2021Sell1,000$30.23$30,230.0057,529View SEC Filing Icon  
7/1/2021Sell1,000$31.75$31,750.00View SEC Filing Icon  
6/14/2021Sell2,000$40.00$80,000.0060,529View SEC Filing Icon  
5/17/2021Sell1,000$19.87$19,870.0063,529View SEC Filing Icon  
4/15/2021Sell1,000$21.14$21,140.0063,445View SEC Filing Icon  
3/15/2021Sell1,000$21.91$21,910.0065,445View SEC Filing Icon  
3/1/2021Sell1,000$18.60$18,600.0066,445View SEC Filing Icon  
2/16/2021Sell1,000$21.81$21,810.00View SEC Filing Icon  
2/1/2021Sell1,000$19.99$19,990.0066,414View SEC Filing Icon  
1/15/2021Sell1,000$21.05$21,050.0068,245View SEC Filing Icon  
1/4/2021Sell1,000$19.75$19,750.0069,189View SEC Filing Icon  
12/15/2020Sell1,000$24.55$24,550.0070,209View SEC Filing Icon  
12/1/2020Sell1,000$21.83$21,830.0070,938View SEC Filing Icon  
11/16/2020Sell1,000$20.25$20,250.0067,414View SEC Filing Icon  
10/15/2020Sell1,000$35.76$35,760.0065,058View SEC Filing Icon  
10/12/2020Sell2,000$40.20$80,400.0066,058View SEC Filing Icon  
10/1/2020Sell1,000$31.18$31,180.0068,058View SEC Filing Icon  
9/15/2020Sell1,000$36.14$36,140.0066,858View SEC Filing Icon  
9/1/2020Sell1,000$26.24$26,240.0067,858View SEC Filing Icon  
8/17/2020Sell1,000$24.76$24,760.0068,858View SEC Filing Icon  
8/3/2020Sell1,000$21.54$21,540.0069,858View SEC Filing Icon  
7/15/2020Sell1,000$28.76$28,760.0070,858View SEC Filing Icon  
7/1/2020Sell1,000$28.61$28,610.0071,858View SEC Filing Icon  
6/15/2020Sell1,000$20.95$20,950.0072,858View SEC Filing Icon  
6/1/2020Sell1,000$18.50$18,500.0073,858View SEC Filing Icon  
5/22/2020Sell7,500$18.02$135,150.00View SEC Filing Icon  
See Full Table

William Ho Buying and Selling Activity at RAPT Therapeutics

This chart shows William Ho's buying and selling at RAPT Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

RAPT Therapeutics Company Overview

RAPT Therapeutics logo
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.
Read More

Today's Range

Now: $23.61
Low: $23.52
High: $25.50

50 Day Range

MA: $33.40
Low: $23.61
High: $40.22

2 Week Range

Now: $23.61
Low: $14.89
High: $43.26


349,107 shs

Average Volume

311,417 shs

Market Capitalization

$697.58 million

P/E Ratio


Dividend Yield



“Move your money by early 2022,” Wall Street legend warns
A new form of technology will cause a massive shift in the wealth divide in 2022. Do you own the stocks that will be affected?
Details here…